The bond market has entered a financial twilight zone, and at this point, there doesn't seem to be a smooth way out.Market Insiderread more
"I think (rate cuts) will help, but whether they're going to be sufficient to counter the negative trade pressures and global growth slowdown and impact is debatable," one...Central Banksread more
China has used both monetary and fiscal measures to lift economic activity as its trade war with the U.S. looks set to intensify in the coming months.China Economyread more
Alibaba held a board meeting before its latest quarterly earnings release last week, during which the board decided to postpone the Hong Kong listing, Reuters reported.Technologyread more
President Donald Trump said on Twitter he was postponing a scheduled meeting with Denmark's prime minister because of her lack of interest in discussing a possible sale of...World Politicsread more
The two countries want to smash the civil aerospace duopoly enjoyed by Airbus and Boeing.Aerospace & Defenseread more
Federal Reserve Chairman Jerome Powell is set to deliver his annual speech on Friday at the Jackson Hole, Wyoming symposium, where he's expected to provide more clarity on the...Asia Marketsread more
After Elon Musk touts Tesla solar on Twitter, Walmart sues the electric vehicle and clean energy company over store rooftop panels that ignited.Technologyread more
U.S. and Asian investors poured $3.7 billion into U.K. tech start-ups in the first seven months of 2019, research shows.Technologyread more
Trump said he has "been thinking about payroll taxes for a long time" — and he cautioned that "whether or not we do something now, it's not being done because of recession."Politicsread more
Secretary of State Mike Pompeo privately told business executives and free traders that the trade war could end by the 2020 election and that hurdles to an immediate agreement...2020 Electionsread more
Novartis CEO Vasant Narasimhan told employees in an internal memo Thursday that "yesterday was not a good day" for the company, after the pharmaceutical giant revealed that it paid $1.2 million to President Donald Trump's personal lawyer, Michael Cohen.
Narasimhan said "we made a mistake" in entering a contract in February 2017 with Cohen through his company, Essential Consultants, for guidance "as to how the Trump administration might approach certain US healthcare policy matters."
"As a consequence, [we] are being criticized by a world that expects more from us," Narasimhan said in the internal email, which was obtained by CNBC.
In a statement Wednesday, Novartis said that the one-year agreement, for which Essential Consultants was paid $100,000 per month, "predated Vas Narasimhan becoming Novartis CEO and he was in no way involved with this agreement."
Novartis also said in the statement that it had been contacted by special counsel Robert Mueller's office in November 2017 regarding the agreement.
Payments from Novartis to Cohen's company were first alleged in an explosive report from lawyer Michael Avenatti, whose client, porn star Stormy Daniels, is suing Trump and Cohen to void a nondisclosure deal that bars her from discussing an alleged affair.
Avenatti's report claimed Novartis had paid Essential Consultants nearly $400,000; in the Wednesday statement, Novartis revealed that it had paid $1.2 million to Cohen's company.
Read Narasimhan's full email below:
Yesterday was not a good day for Novartis. Many of you will have seen media reports regarding Novartis' relationship with Essential Consultants in the United States and many of you will feel disappointed and frustrated. You can read our full statement here. We made a mistake in entering into this engagement and, as a consequence, are being criticized by a world that expects more from us.
Personally and for my family, it was also a difficult day, as unfounded stories spread through the US news. While I was not involved with any aspect of this situation, the facts did not matter. I went to sleep frustrated and tired.
But I woke up this morning full of determination. Determined to fight for the transformative medicines we create and the patients we serve. Determined to fight for this company I deeply love. Determined to fight for all of you so you continue to feel proud, inspired and empowered to transform the health of the world every day. This moment will pass and we will learn. Our medicines however will endure for generations.
What defines us now is as how we respond to this difficult situation. I look to you to remain resilient and keep your focus on serving patients. Together we will respond by continuing our work to profoundly impact human health. Please focus on that noble purpose in this difficult moment — bending the curve of life.